End of the year for edit seems extremely positive. Results and further company plans will be out to the public. Working on cure for blindness as well as positive tumor shrinking results. This company should be massive but as of now in debt and extremely speculative. Hence the volatility. Is 25$ a reasonable price? Yes in my veiw extremely undervalued. Howver the TA shows the clear volatility and emptiobal ride. Short term we lost some support that was extremely important around 27.50 Howver as of now double bottomed at recent low and broke a smaller wedge. Our larger wedge resistance up at 28 we want to see a powerful move and backtest as support. If we can push through and confirm that downtrendinf resiatnce as support this would be a great start! I am keeping eyes on edit for a safe entry above 28$ would be a great safe entry if it can hold